WASHINGTON, D.C. – Pierre Kory, M.D., president and chief medical officer of the FLCCC, testified in Brussels, Belgium today as part of an international delegation of physicians, scientists, and legal experts that members of the European Parliament invited to discuss the significant impact the global pandemic response had on public health and what policy changes to consider in protecting the practice of medicine and integrity of scientific data in the future.
In his testimony, Dr. Kory discussed how corporate interests heavily influenced health policy decisions to favor using new and expensive treatments that were largely ineffective and often harmful over less costly and well-known treatments already proven effective in treating COVID-19. Dr. Kory also provided details on the extensive data supporting the efficacy and safety of ivermectin, which government officials worldwide ignored leading to hospitals prohibiting the drug’s use and medical authorities punishing doctors for prescribing it for treating COVID-19.
“The policy decisions guided by the medical recommendations of public health agencies and lawmakers worldwide are looking worse by the day,” said Pierre Kory, M.D., M.P.A., president and chief medical officer of the FLCCC. “I am encouraged by the interest of the members of parliament who will participate in discussion with us this week. I hope the conversation continues and leads to real change to prevent the horrible policies made in response to COVID-19.”
The testimonies of the international delegation were heard by members of parliament representing several European countries including Germany, Romania, Croatia, and Italy, and will be translated into seven different languages.
More information on the delegation and an archive of the proceedings can be found here: https://www.internationalcovidsummit.com or at Children’s Health Defense
About the Front Line COVID-19 Critical Care Alliance
The FLCCC Alliance was organized in March 2020 by a group of highly published, world renowned critical care physicians and scholars with the academic support of allied physicians from around the world. FLCCC’s goal is to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness including the I-RECOVER protocols for “Long COVID” and Post Vaccine Syndrome. For more information: www.FLCCC.net